Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives. 2014

Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, KeXue DaDao, Zhengzhou 450001, China.

Trying to develop potent and selective anticancer agents, two series of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives were designed and synthesized. Their antitumor activities were evaluated by MTT method against four selected human cancer cell lines (MGC-803, EC-9706, HeLa and MCF-7). Our results showed that compound 11h exhibited good anticancer activities compared to 5-fluorouracil against the four tested cell lines, with IC50 values ranging from 2.0 to 4.5 μM. Flow cytometry analysis indicated that compound 11h induced the cellular early apoptosis and cell cycle arrest at G2/M phase in EC-9706.

UI MeSH Term Description Entries
D010793 Phthalazines Bicyclic heterocyclic compounds containing a BENZENE ring fused to PYRIDAZINE.
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
October 2009, Acta crystallographica. Section E, Structure reports online,
Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
April 2014, Bioorganic & medicinal chemistry letters,
Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
August 2013, Journal of enzyme inhibition and medicinal chemistry,
Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
November 2010, European journal of medicinal chemistry,
Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
March 2016, Bioorganic & medicinal chemistry letters,
Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
May 2013, Chemical biology & drug design,
Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
November 2022, Molecules (Basel, Switzerland),
Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
April 2007, European journal of medicinal chemistry,
Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
February 2011, European journal of medicinal chemistry,
Deng-Qi Xue, and Xu-Yao Zhang, and Chao-Jie Wang, and Li-Ying Ma, and Nan Zhu, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Xiao-Song Zhang, and Cai-Feng Wang, and Cong-Hui Ji, and Qiu-Rong Zhang, and Hong-Min Liu
November 1997, Die Pharmazie,
Copied contents to your clipboard!